do glp 1 reduce cancer risk Dr Semaglutide: What we know about

The choice between a once-weekly injectable versus a daily oral medication can significantly affect a patients medication adherence

GLP-1 is glucagon-like peptide, a hormone that the body produces on its own

This is not a failure of willpower its biology

Eur J Endocrinol

I enjoy it, and it's part of my life, but I don't have to force myself

That evidence may matter significantly for patients with: Prior heart attack Stroke history Significant cardiovascular risk factors Patients Who Prefer Weekly Rather Than Daily Dosing Some people are actually more consistent with once-weekly routines than with daily medications